Naviter Wealth’s MAIA Biotechnology MAIA Stock Holding History

Naviter Wealth’s Portfolio MAIA Stock Details MAIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$16.2K	–	299
2025 Q1	$16.2K	Buy	+10,000	New	+$18.5K	﹤0.01%	272
2024 Q4	–	Sell	-22,168	Closed	-$62.3K	–	294
2024 Q3	$62.3K	Hold	22,168	–	–	0.01%	242
2024 Q2	$75.8K	Hold	22,168	–	–	0.01%	230
2024 Q1	$48.8K	Hold	22,168	–	–	0.01%	231
2023 Q4	$25.9K	Hold	22,168	–	–	0.01%	218
2023 Q3	$48.8K	Hold	22,168	–	–	0.01%	210
2023 Q2	$48.8K	Buy	+22,168	New	+$59.3K	0.01%	230

Other funds holding MAIA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CAG

Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return

Naviter Wealth's MAIA Position: Q2 2025 in Review

Naviter Wealth sold out of MAIA Biotechnology (MAIA) in Q2 2025, closing a stake of 10,000 shares — an estimated $16.2K sold.

Naviter Wealth first reported a position in MAIA in Q2 2023 and held it in 7 quarters. The position peaked at $75.8K in Q2 2024. 20 funds tracked by Wall St. Rank hold MAIA as of Q2 2025.

Naviter Wealth reported no remaining MAIA Biotechnology position as of Q2 2025 after selling out during the quarter.
Naviter Wealth sold 10,000 MAIA Biotechnology shares in Q2 2025, an estimated $16.2K.
Naviter Wealth first reported a position in MAIA Biotechnology in Q2 2023 and held it in 7 quarters.
Naviter Wealth's MAIA Biotechnology position peaked at $75.8K in Q2 2024.
20 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2025.

Based on Naviter Wealth's 13F filing for Q2 2025, filed 28 Jul 2025.